| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
centriolar coiled-coil protein 110 | 0.821 | 0.115 | 6.7E-03 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2000 | 2008 | ||||||||
|
zinc finger AN1-type containing 2B | 0.931 | 0.115 | 2.5E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
immunoglobulin heavy joining 2 | 0.931 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
serine protease 27 | 0.805 | 0.154 | 8.0E-05 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
coiled-coil domain containing 28A | 0.780 | 0.154 | 3.6E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
FGFR1 oncogene partner 2 | 0.890 | 0.154 | 5.0E-04 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2013 | ||||||||
|
EF-hand calcium binding domain 6 | 0.890 | 0.154 | 1.2E-45 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
Cbl proto-oncogene C | 0.821 | 0.192 | 4.2E-11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cysteine and histidine rich domain containing 1 | 0.792 | 0.192 | 0.90 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
heterogeneous nuclear ribonucleoprotein H3 | 0.839 | 0.192 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
transmembrane protein 207 | 0.792 | 0.231 | 4.2E-11 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
polykaryocytosis promoter | 0.792 | 0.231 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
pleckstrin 2 | 0.729 | 0.231 | 5.3E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
DnaJ heat shock protein family (Hsp40) member C17 | 0.839 | 0.231 | 2.0E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
L3MBTL histone methyl-lysine binding protein 1 | 0.729 | 0.269 | 1.5E-12 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2010 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
single stranded DNA binding protein 2 | 0.659 | 0.269 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
BCR pseudogene 3 | 0.705 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
death inducer-obliterator 1 | 0.751 | 0.308 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ETS variant transcription factor 7 | 0.736 | 0.308 | 4.0E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
protein kinase cGMP-dependent 2 | 0.705 | 0.308 | 0.65 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
chromatin target of PRMT1 | 0.722 | 0.346 | 0.76 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2013 | ||||||||
|
coiled-coil domain containing 88C | 0.647 | 0.346 | 3.3E-08 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
biogenesis of lysosomal organelles complex 1 subunit 2 | 0.760 | 0.346 | 1.2E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
septin 6 | 0.644 | 0.385 | 0.93 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 |